AU751571B2 - Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof - Google Patents
Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof Download PDFInfo
- Publication number
- AU751571B2 AU751571B2 AU49085/99A AU4908599A AU751571B2 AU 751571 B2 AU751571 B2 AU 751571B2 AU 49085/99 A AU49085/99 A AU 49085/99A AU 4908599 A AU4908599 A AU 4908599A AU 751571 B2 AU751571 B2 AU 751571B2
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- polypeptide
- cap
- allergies
- snurportin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19831382A DE19831382A1 (de) | 1998-07-14 | 1998-07-14 | Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung |
DE19831382 | 1998-07-14 | ||
PCT/EP1999/004750 WO2000004144A1 (de) | 1998-07-14 | 1999-07-07 | Snurportin 1, humanes m3g-cap-spezifisches kernimportrezeptorprotein mit einer neuen domänenstruktur, dessen herstellung und verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4908599A AU4908599A (en) | 2000-02-07 |
AU751571B2 true AU751571B2 (en) | 2002-08-22 |
Family
ID=7873911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU49085/99A Ceased AU751571B2 (en) | 1998-07-14 | 1999-07-07 | Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1097201A1 (de) |
JP (1) | JP2002520052A (de) |
AU (1) | AU751571B2 (de) |
CA (1) | CA2333895A1 (de) |
DE (1) | DE19831382A1 (de) |
WO (1) | WO2000004144A1 (de) |
-
1998
- 1998-07-14 DE DE19831382A patent/DE19831382A1/de not_active Withdrawn
-
1999
- 1999-07-07 EP EP99932844A patent/EP1097201A1/de not_active Withdrawn
- 1999-07-07 JP JP2000560242A patent/JP2002520052A/ja active Pending
- 1999-07-07 WO PCT/EP1999/004750 patent/WO2000004144A1/de not_active Application Discontinuation
- 1999-07-07 AU AU49085/99A patent/AU751571B2/en not_active Ceased
- 1999-07-07 CA CA002333895A patent/CA2333895A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2333895A1 (en) | 2000-01-27 |
WO2000004144A1 (de) | 2000-01-27 |
DE19831382A1 (de) | 2000-02-03 |
AU4908599A (en) | 2000-02-07 |
JP2002520052A (ja) | 2002-07-09 |
EP1097201A1 (de) | 2001-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU707598B2 (en) | Cell death protein | |
Bunz et al. | cDNAs encoding the large subunit of human replication factor C. | |
CN112105728B (zh) | CRISPR/Cas效应蛋白及系统 | |
Chen et al. | Sequence and expression in Escherichia coli of the 40-kDa subunit of activator 1 (replication factor C) of HeLa cells. | |
US6376661B1 (en) | Human RNase H and compositions and uses thereof | |
CA2264546A1 (en) | Two human cathepsin proteins | |
JP3181660B2 (ja) | ビリルビンオキシダーゼの製造法 | |
CA2303760A1 (en) | A potential effector for the grb7 family of signalling proteins | |
US6492168B1 (en) | Methyltransferase gene and enzyme | |
AU751571B2 (en) | Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof | |
KR102043356B1 (ko) | 마크로포미나 파세올리나로부터의 리그닌 분해 효소 및 이의 용도 | |
JP2003210183A (ja) | ヒトIκB−β | |
AU733462B2 (en) | CYP7 promoter-binding factors | |
AU735512B2 (en) | Modulators of BRAC1 activity | |
EP1007677B1 (de) | Protease-ähnliches protein | |
JP4232423B2 (ja) | 新規ユビキチン特異プロテアーゼ | |
US6919427B1 (en) | Polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide | |
AU777034B2 (en) | Human RNase H and compositions and uses therof | |
KR100191125B1 (ko) | 마우스에서 분리한 신규의 swi3계 유전자 및 그로부터 발현되는 단백질 | |
JP3243531B2 (ja) | 機能性タンパク質のスクリーニング方法 | |
US20030144496A1 (en) | Human RNase H and compositions and uses thereof | |
JP2003159080A (ja) | 痛みに関連する分子の同定及び使用 | |
US6994996B1 (en) | Polypeptide, human vacuolar H+ -ATPase C subunit 42 and polynucleotide encoding it | |
US6703201B1 (en) | Human PEC-60-like protein and DNA encoding this protein | |
AU727305B2 (en) | A potential effector for the GRB7 family of signalling proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |